Versant Capital Management, Inc Dexcom Inc Transaction History
Versant Capital Management, Inc
- $710 Million
- Q3 2025
A detailed history of Versant Capital Management, Inc transactions in Dexcom Inc stock. As of the latest transaction made, Versant Capital Management, Inc holds 431 shares of DXCM stock, worth $25,092. This represents 0.0% of its overall portfolio holdings.
Number of Shares
431
Previous 450
4.22%
Holding current value
$25,092
Previous $39,000
25.64%
% of portfolio
0.0%
Previous 0.01%
Shares
18 transactions
Others Institutions Holding DXCM
# of Institutions
1,106Shares Held
366MCall Options Held
5.36MPut Options Held
5.18M-
Vanguard Group Inc Valley Forge, PA48.3MShares$2.81 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.01 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.9MShares$981 Million0.06% of portfolio
-
Baillie Gifford & CO15.9MShares$925 Million0.84% of portfolio
-
Geode Capital Management, LLC Boston, MA10.8MShares$627 Million0.07% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $22.5B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...